Institutional Core Labs
- iLab
- Bioanalytics & Single-Cell
- Biospecimen and Translational Genomics
- Flow Cytometry
- Mass Spectometry
- Optical Imaging
- Structural Biology (NMR)
- Structural Biology (X-Ray Crystallography)
Find a Researcher
Research by School
VPR Applications Support & IT
Additional Resources
- Environmental Health & Safety
- Council of Principal Investigators
- National Academy of Inventors
- Office of Technology Commercialization
- Postdoc Positions
- Report A Discovery
- Research Directory
- Researcher Resources
- San Antonio Bioscience Research
- San Antonio Partnership for Precision Therapeutics
- Spotlight on Research Integrity
Dry Mouth and Salivary Gland Dysfunction
Dry mouth, or xerostomia, is a common condition affecting roughly 25 percent of all women and 20 percent of men between the ages of 18 to 88. The prevalence of the condition increases with age. The most common cause of xerostomia is a side effect of medications or of systemic diseases such as Sjogren’s syndrome.
The Latest Facts & Findings
Our research focuses improving oral comfort and quality of life of in individuals by either stimulating saliva production or using agents that have the potential to address the underlying cause of the systemic disease.
4 million
people have Sjogren’s syndrome in the United States.
Xerogenic
drugs can be found in 42 drug categories and 56 subcategories.
Research into this condition has the greatest impact on the quality of life in those who have this prevalent and sometimes devastating ailment. Fresh ideas may stimulate the development of novel treatments and therapeutics that would benefit the community
Dr. Vidya Sankar